The FDA is holding a forum this month to address MRI safety concerns and find ways to cut incidents. Industry leaders agree there should be safety standards in place, but are mixed on whether federal regulation is needed. What do you think?
The FDA is holding a forum this month to address MRI safety concerns and find ways to cut incidents. Industry leaders agree there should be safety standards in place, but are mixed on whether federal regulation is needed.
What do you think? Vote here and tell us more in the comments below.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.